|
|
| Research article summary (published 30 Dec 2006): |
[The use of lucetam for improvement of cognitive functions in chronic cerebrovascular insufficiency (clinical and encephalographic study)]
Full Abstract
One hundred and ninety-three patients, aged 35-60 years, with chronic cerebrovascular insufficiency of I and II stage have been studied. It has been shown that memory and attention disturbances at stage I are of pseudomnemonic character. At stage II, the syndrome of mild cognitive impairment is formed first with the following formation of the moderate one. After the treatment with lucetam, the overall improvement as measured by neurophysiological testing was observed in 64% of patients, the memory improvement - in 18%, the attention improvement - in 10% and no positive effect was found in 8%. The significant improvement of cognitive functioning was correlated with positive changes of brain neurodynamics in the EEG study.
Author information
Author/s: Bugrova, S G (SG); Novikov, A E (AE);
Journal and publication information
Publication Type: Comparative Study; English Abstract; Journal Article
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova / Ministerstvo zdravookhraneniia i meditsinskoi promyshlennosti Rossiiskoi Federatsii, Vserossiiskoe obshchestvo nevrologov [i] Vserossiiskoe obshchestvo psikhiatrov (Zh Nevrol Psikhiatr Im S S Korsakova), published in Russia (Federation). (Language: rus)
Reference: 2007-; vol 107 (issue 4) : pp 44-8
Dates: Created 2008/04/01; Completed 2008/08/26;
PMID: 18379503, status: MEDLINE (last retrieved date: 2/18/2009)
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MeSH Headings (categories) shown below.
Note: Bold headings indicate primary MeSH headings or qualifiers.
Associated Chemicals: Neuroprotective Agents (0) ; Piracetam (7491-74-9)Related articles
These are the most related articles currently in our database:
- [The use of memotropil for treatment of mild cognitive impairment in out-patients with progressive chronic cerebrovascular disorders]
30 Dec 2007 - [The use of the combined drug vinpotropil at early stages of cerebrovascular insufficiency]
30 Dec 2006 - Neurocognitive effects of ziprasidone and related factors in patients with chronic schizophrenia undergoing usual care: a 12-month, open-label, flexible-dose, naturalistic observational trial.
29 Jun 2008 - [Sudden hearing loss. Treatment with piracetam]
30 Dec 1996 - [Cognitive disturbances and dysfunction of neuromediator systems in cerebral vascular insufficiency after treatment with pronoran]
30 Dec 2006 - [Effects of piracetam on the cognitive functions verified by electrophysiologic methods]
17 May 2002 - Efficacy of piracetam in the treatment of tardive dyskinesia in schizophrenic patients: a randomized, double-blind, placebo-controlled crossover study.
29 Jun 2007 - Acute treatment of stroke. PASS group. Piracetam Acute Stroke Study.
23 Jul 1998 - [The metabolic therapy of ischemic stroke: the use of nootropil]
30 Dec 1996 - Clinical efficacy of piracetam in cognitive impairment: a meta-analysis.
30 Dec 2001
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a larger map of 100+ related articles.